Contracts › HT942525C0004
HT942525C0004: Dha Sttr Phase Ii Proposal H2-0804, Titled "Shelf-Stable Antibiotic Hybrid Exosomes for the Topical Treatment of Wound Infections", Medical R&D Contract.
Awarded to Luna Labs Usa Llc by Defense Health Agency.
$1.3Mobligated
$1.3Mpotential value
04 June 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942525C0004 |
|---|---|
| Awardee | Luna Labs Usa Llc |
| Awarding agency | Defense Health Agency |
| Awarding office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | VA |
| Offers received | 4 |
| Period of performance | 05 February 2025 to 04 June 2027 |
| Potential end | 04 June 2027 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record